Patents by Inventor Robert Lavker

Robert Lavker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ACTIVE LOW MOLECULAR WEIGHT VARIANTS OF ANGIOTENSIN CONVERTING ENZYME 2 (ACE2) FOR THE TREATMENT OF DISEASES AND CONDITIONS OF THE EYE
    Publication number: 20210386837
    Abstract: Disclosed herein are compositions and methods useful for treating diseases and conditions of the cornea in a subject in need thereof, comprising administering a therapeutically effective amount of an angiotensin converting enzyme 2 (ACE2) and/or variants of ACE2 to the subject. The disclosed variants of ACE2 may include fragments of ACE2 having ACE2 biological activity for converting AngII (1-8) to Ang (1-7).
    Type: Application
    Filed: May 18, 2021
    Publication date: December 16, 2021
    Inventors: Daniel Batlle, Jan Wysocki, Robert Lavker
  • Reduction of cutaneous atrophy
    Patent number: 5807600
    Abstract: The cutaneous atrophy associated with the use of steroids topically can be ameliorated using salts of certain .alpha.-hydroxyacids.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: September 15, 1998
    Assignee: Bristol-Myers Squibb Company
    Inventors: Prakash Parab, Robert Lavker, James Leyden
  • Reduction of cutaneous atrophy
    Patent number: 5254343
    Abstract: The cutaneous atrophy associated with the use of steroids topically can be ameliorated using salts of certain .alpha.-hydroxyacids.
    Type: Grant
    Filed: February 13, 1992
    Date of Patent: October 19, 1993
    Assignee: Bristol-Myers Squibb Company
    Inventors: Prakash Parah, Robert Lavker, James Levden